Related Experiment Videos
Proteomics in tumor progression and metastasis
Patrick A Everley1, Bruce R Zetter
1Department of Surgery, Children's Hospital / Harvard Medical School, Boston, Massachusetts 02115, USA.
Annals of the New York Academy of Sciences
|December 31, 2005
Summary
Proteomics, the study of proteins, uses mass spectrometry to analyze cancer-related proteins. This review explores proteomic technologies for understanding tumor progression and metastasis.
Area of Science:
- Proteomics and Cancer Biology
Background:
- Proteomics aims to systematically identify and characterize proteins within organisms.
- Advancements in mass spectrometry have enabled quantitative and functional proteomic analyses.
- Proteins play crucial roles in various biological processes, including cancer development.
Purpose of the Study:
- To review the application and potential of proteomic technologies in studying tumor progression.
- To highlight the use of proteomics in understanding the molecular mechanisms of metastasis.
- To discuss the latest techniques for analyzing temporal changes in protein levels during tumor development.
Main Methods:
- Mass spectrometry-based proteomics.
- Quantitative proteomics techniques (e.g., SILAC, TMT).
- Functional proteomics assays.
Main Results:
- Proteomic analyses have identified numerous proteins implicated in cancer.
- Temporal proteomic studies are revealing dynamic changes in protein expression during tumorigenesis.
- Proteomics aids in understanding the complex molecular networks driving tumor progression and metastasis.
Conclusions:
- Proteomic technologies offer powerful tools for advancing cancer research.
- Continued development and application of proteomics will enhance our understanding of tumor biology.
- Proteomics holds significant promise for the development of novel cancer diagnostics and therapeutics.